MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/advs.202417605

Медицинская библиотека · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025

SCORT-Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo.

Cui Zhifen, Huang Furong, Fang Kun, Yan Jingyue, Zhang Yuebao, Kang Diana D, Zhou Yufan, Zhao Yue, Everitt Jeffrey I, Hankey William, Armstrong Andrew J, Huang Jiaoti, Wang Hongyan, Jin Victor X, Dong Yizhou, Wang Qianben

СтатьяПеревод в очереди

Аннотация

Metastatic cancer, the primary cause of cancer mortality, frequently exhibits heightened dependence on certain transcription factors (TFs), which serve as master regulators of oncogenic signaling yet are often untargetable by small molecules. Selective Cell in ORgan Targeting (SCORT) nanoparticles are developed for precise CRISPR/Cas13d mRNA and gRNA delivery to metastatic cancer cells in vivo, aiming to knock down the undruggable oncogenic TF HoxB13. In prostate cancer liver metastasis models driven by HoxB13, repeated systemic SCORT-Cas13d-gHoxB13 treatment significantly decreases HoxB13 expression, reduces metastasis, and extends mouse survival. Prolonged treatment shows no significant impact on major organ function, histology or immune markers. Mechanistically, SCORT-Cas13d-gHoxB13 treatment suppresses metastatic tumor proliferation and angiogenesis while promoting apoptosis by regulating multiple gene pathways. Unexpectedly, it inhibits the non-canonical, EMT-independent oncogenic function of Snail. These findings suggest that SCORT-Cas13d-gHoxB13 can effectively and safely target the undruggable HoxB13 in metastatic prostate cancer, positioning CRISPR/Cas13d as a potential treatment.

Для цитирования: Cui Zhifen, Huang Furong, Fang Kun, Yan Jingyue, Zhang Yuebao, Kang Diana D, Zhou Yufan, Zhao Yue, Everitt Jeffrey I, Hankey William, Armstrong Andrew J, Huang Jiaoti, Wang Hongyan, Jin Victor X, Dong Yizhou, Wang Qianben. SCORT-Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo.. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2025. DOI: 10.1002/advs.202417605.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.